2. Search Result
Search Result
Results for "

short-acting

" in MedChemExpress (MCE) Product Catalog:

44

Inhibitors & Agonists

3

Peptides

1

Natural
Products

10

Isotope-Labeled Compounds

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-B0422
    Nateglinide

    A4166; Senaglinide

    		 Potassium Channel Dipeptidyl Peptidase Metabolic Disease
    Nateglinide, a D-phenylalanine derivative, is an orally active and short-acting insulinotropic agent and a DPP IV inhibitor. Nateglinide inhibits ATP-sensitive K + channels in pancreatic β-cells. Nateglinide is used for the treatment of type 2 (non-insulin-dependent) diabetes mellitus .
    Nateglinide
  • HY-B0507A
    Sulfathiazole sodium
    3 Publications Verification

    		 Bacterial Antibiotic Infection
    Sulfathiazole sodium is an organosulfur compound that has been used as a short-acting sulfa drug.
    Sulfathiazole sodium
  • HY-B0507
    Sulfathiazole
    3 Publications Verification

    		 Bacterial Antibiotic Infection
    Sulfathiazole, an organosulfur compound, is used as a short-acting sulfonamide antibiotic .
    Sulfathiazole
  • HY-B0436
    Salbutamol hemisulfate
    2 Publications Verification

    Albuterol hemisulfate; AH-3365 hemisulfate

    		 Adrenergic Receptor Autophagy Inflammation/Immunology Endocrinology Cancer
    Salbutamol Hemisulfate (Albuterol hemisulfate) is a short-acting β2 adrenergic receptor agonist Target: β2 Adrenergic Receptor Salbutamol Hemisulfate (Albuterol hemisulfate) is a short-acting, selective beta2-adrenergic receptor agonist used in the treatment of asthma and COPD.
    Salbutamol hemisulfate
  • HY-B1288A
    Oxybuprocaine

    Benoxinate; Novesinol; Oxybucaine
    Oxybuprocaine is a short-acting ester-type local anesthetic agent used in ophthalmology and otolaryngology .
    Oxybuprocaine
  • HY-17436
    Clevidipine

    		Calcium Channel Cardiovascular Disease Cancer
    Clevidipine is a short-acting dihydropyridine calcium channel antagonist (IC50= 7.1 nM, V(H) = -40 mV ).
    Clevidipine
  • HY-17457
    Levalbuterol tartrate

    Levosalbutamol tartrate

    		 Adrenergic Receptor Neurological Disease Endocrinology
    Levosalbutamol tartrate(levalbuterol) is the R-enantiomer of the short-acting β2-adrenergic receptor agonist salbutamol.
    Levalbuterol tartrate
  • HY-101939
    RP-001

    		LPL Receptor Neurological Disease
    RP-001 is a picomolar short-acting S1P1 (EDG1) selective agonist, with an EC50 of 9 pM. RP-00 induces internalization and polyubiquitination of S1P1. RP-001 has little activity on S1P2-S1P4 and only moderate affinity for S1P5 .
    RP-001
  • HY-101939A
    RP-001 hydrochloride

    		LPL Receptor Neurological Disease
    RP-001 hydrochloride is a picomolar short-acting S1P1 (EDG1) selective agonist, with an EC50 of 9 pM. RP-00 hydrochloride induces internalization and polyubiquitination of S1P1. RP-001 hydrochloride has little activity on S1P2-S1P4 and only moderate affinity for S1P5 .
    RP-001 hydrochloride
  • HY-B0507S
    Sulfathiazole-d4

    		Isotope-Labeled Compounds Bacterial Infection
    Sulfathiazole-d4 is a deuterium labeled Sulfathiazole. Sulfathiazole, an organosulfur compound, is used as a short-acting sulfonamide antibiotic[1].
    Sulfathiazole-d4
  • HY-B0304AS
    Dapoxetine-d7 hydrochloride

    LY-210448-d7 (hydrochloride)

    		 Serotonin Transporter Neurological Disease
    Dapoxetine-d7 (hydrochloride) is the deuterium labeled Dapoxetine hydrochloride. Dapoxetine hydrochloride is a short-acting selective serotonin reuptake inhibitor (SSRI)[1].
    Dapoxetine-d7 hydrochloride
  • HY-15105
    SB-423562

    		CaSR Inflammation/Immunology
    SB-423562 is a short-acting calcium-sensing receptor (CaR) antagonist. SB-423562 has the potential for osteoporosis research.
    SB-423562
  • HY-B1481B
    Isoetharine hydrochloride

    Isoetarine hydrochloride

    		 Others Infection
    Isoetharine hydrochloride is selective, short-acting and orally active β-agonist which is widely used as a bronchodilator in the research of inhalation research .
    Isoetharine hydrochloride
  • HY-B1784
    Sulfisomidin

    Sulfaisodimidine

    		 Bacterial Antibiotic Infection
    Sulfisomidin (Sulfaisodimidine) is an orally active short-acting sulfonamide antibacterial. Sulfisomidin can be used for the research of lower urinary tract infections .
    Sulfisomidin
  • HY-16472
    Sulfacytine

    		Antibiotic Bacterial Infection
    Sulfacytine is a short-acting sulfonamide antibiotic. Sulfacytine is active against bacteria and is an effective agent for the research of acute uncomplicated urinary tract infections .
    Sulfacytine
  • HY-B0304AS1
    Dapoxetine-d6 hydrochloride

    LY-210448-d6 hydrochloride

    		 Isotope-Labeled Compounds Serotonin Transporter Neurological Disease
    Dapoxetine-d6 (LY-210448-d6) hydrochloride is the deuterium labeled Dapoxetine hydrochloride. Dapoxetine hydrochloride is a short-acting selective serotonin reuptake inhibitor (SSRI)
    Dapoxetine-d6 hydrochloride
  • HY-116457
    Propanidid

    Sombrevin; Fabantol

    		 GABA Receptor Neurological Disease
    Propanidid (Sombrevin; Fabantol) is a γ-aminobutyric acid type A (GABAA) receptor agonist and a short-acting non-barbiturate general anesthetic agent. Propanidid can decrease the arterial pressure .
    Propanidid
  • HY-135230
    LY2444296

    FP3FBZ

    		 Opioid Receptor Neurological Disease
    LY2444296 is an orally bioavailable, high-affinity and selective short-acting kappa opioid receptor (KOPR) antagonist, with a Ki value of ∼1 nM. LY2444296 exhibits anti-anxiety like effects .
    LY2444296
  • HY-106450
    Binodenoson

    MRE-0470; WRC 0470

    		 Adenosine Receptor Cardiovascular Disease
    Binodenoson (MRE-0470) is a potent and selective A2A adenosine receptor agonist (KD=270 nM). Binodenoson is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging .
    Binodenoson
  • HY-B1675A
    Levalbuterol hydrochloride

    (R)-Albuterol hydrochloride; (R)-Salbutamol hydrochloride; Levosalbutamol hydrochloride
    Levalbuterol ((R)-Albuterol) hydrochloride is a short-acting β2-adrenergic receptor agonist and the active (R)-enantiomer of Salbutamol. Levalbuterol hydrochloride is a more potent bronchodilator than Salbutamol and has the potential for the treatment of COPD .
    Levalbuterol hydrochloride
  • HY-17436S1
    Clevidipine-d7

    		Isotope-Labeled Compounds Calcium Channel Cardiovascular Disease
    Clevidipine-d7 is the deuterium labeled Clevidipine. Clevidipine is a short-acting dihydropyridine calcium channel antagonist (IC50= 7.1 nM, V(H) = -40 mV ) under development for treatment of perioperative hypertension[1][2].
    Clevidipine-d7
  • HY-B1037S
    Salbutamol-d3

    Albuterol-d3; AH-3365-d3

    		 Adrenergic Receptor Neurological Disease Endocrinology
    Salbutamol-d3 is the deuterium labeled Salbutamol. Salbutamol is a short-acting β2-adrenergic receptor agonist used for the relief of bronchospasm in conditions such as asthma and chronic obstructive pulmonary disease (COPD).
    Salbutamol-d3
  • HY-B1037S2
    Salbutamol-d9

    Albuterol-d9; AH-3365-d9

    		 Isotope-Labeled Compounds Adrenergic Receptor Neurological Disease Endocrinology
    Salbutamol-d9 is the deuterium labeled Salbutamol. Salbutamol is a short-acting β2-adrenergic receptor agonist used for the relief of bronchospasm in conditions such as asthma and chronic obstructive pulmonary disease (COPD).
    Salbutamol-d9
  • HY-15708
    LY2795050

    		Opioid Receptor Neurological Disease
    LY2795050 is a short-acting selective κκ-opioid receptor (KOR) antagonist. LY2795050 has high affinity for the KOR with Ki value of 0.72 nM. LY2795050 can be used for the research of central nervous system dysfunction .
    LY2795050
  • HY-B1700A
    Mivacurium dichloride

    		nAChR Neurological Disease
    Mivacurium dichloride is a benzylisoquinoline derivative and is a short-acting non-depolarizing neuromuscular blocking agent and skeletal muscle relaxant. Mivacurium dichloride couples with the nAChR to reduce or inhibit the depolarizing effect of acetylcholine on the terminal disc of the muscle cell .
    Mivacurium dichloride
  • HY-106842
    Nitecapone

    OR-462

    		 COMT Neurological Disease Inflammation/Immunology
    Nitecapone (OR-462) is an orally active and short-acting catechol-O-methyltransferase (COMT) inhibitor with gastroprotective and antioxidant properties. Nitecapone (OR-462) scavenges reactive oxygen and nitric radicals and prevents lipid peroxidation .
    Nitecapone
  • HY-B1037S3
    Salbutamol-d9 acetate

    Albuterol-d9 acetate; AH-3365-d9 acetate

    		 Adrenergic Receptor
    Salbutamol-d9 (acetate) is the deuterium labeled Salbutamol[1]. Salbutamol is a short-acting β2-adrenergic receptor agonist used for the relief of bronchospasm in conditions such as asthma and chronic obstructive pulmonary disease (COPD).
    Salbutamol-d9 acetate
  • HY-17436S3
    (R)-Clevidipine-13C,d3

    		Calcium Channel
    (R)-Clevidipine- 13C,d3 is the deuterium and 13C labeled Clevidipine[1]. Clevidipine is a short-acting dihydropyridine calcium channel antagonist (IC50= 7.1 nM, V(H) = -40 mV ) under development for treatment of perioperative hypertension[2].
    (R)-Clevidipine-13C,d3
  • HY-14232
    TTA-A8

    		Calcium Channel Neurological Disease
    TTA-A8 (Compound 13) is a short-acting T-type calcium channel antagonist with oral activity, exhibiting an IC50 value of 31.3 nM in the FLIPR depolarization assay. TTA-A8 possesses favorable pharmacokinetic properties, making it suitable for research on epilepsy and sleep .
    TTA-A8
  • HY-B0422S
    Nateglinide-d5

    A4166 D5; Senaglinide D5
    Nateglinide-d5 is a deuterium labeled Nateglinide. Nateglinide, a D-phenylalanine derivative, is an orally active and short-acting insulinotropic agent and a DPP IV inhibitor. Nateglinide inhibits ATP-sensitive K+ channels in pancreatic β-cells. Nateglinide is used for the treatment of type 2 (non-insulin-dependent) diabetes mellitus[1][2].
    Nateglinide-d5
  • HY-B1037
    Salbutamol
    2 Publications Verification

    Albuterol; AH-3365

    		 Adrenergic Receptor ERK Inflammation/Immunology Cancer
    Salbutamol (Albuterol) is a short-acting beta-2 adrenergic receptor agonist with oral activity. Salbutamol promotes tumorigenesis of gastric cancer cells through the β2-AR/ERK/EMT pathway. Salbutamol is used to study bronchospasms caused by asthma and chronic obstructive pulmonary disease (COPD) .
    Salbutamol
  • HY-17611
    Etripamil

    MSP-2017; (-)-MSP-2017

    		 Calcium Channel Cardiovascular Disease
    Etripamil (MSP-2017) is a short-acting L-type calcium-channel antagonist, can be used for the research of Paroxysmal Supraventricular Tachycardia (PSVT). Etripamil (MSP-2017) slows atrioventricular nodal conduction and prolongs atrioventricular nodal refractory periods by inhibiting calcium ion influx through the calcium slow channels in the atrioventricular node cells .
    Etripamil
  • HY-16056
    Arbutamine

    		Adrenergic Receptor Cardiovascular Disease
    Arbutamine is a short-acting, potent and nonselective β-adrenoceptor agonist. Arbutamine stimulates cardiac β1-, tracheal β2-, and adiopocyte β3- adrenergic receptors. Arbutamine provides cardiac stress increases heart rate, cardiac contractility, and systolic blood pressure. Arbutamine can be used for cardiac stress agent .
    Arbutamine
  • HY-16056A
    Arbutamine hydrochloride

    		Adrenergic Receptor Cardiovascular Disease
    Arbutamine hydrochloride is a short-acting, potent and nonselective β-adrenoceptor agonist. Arbutamine hydrochloride stimulates cardiac β1-, tracheal β2-, and adiopocyte β3- adrenergic receptors. Arbutamine hydrochloride provides cardiac stress increases heart rate, cardiac contractility, and systolic blood pressure. Arbutamine hydrochloride can be used for cardiac stress agent .
    Arbutamine hydrochloride
  • HY-B1037R
    Salbutamol (Standard)

    Albuterol (Standard); AH-3365 (Standard)

    		 Adrenergic Receptor ERK Inflammation/Immunology Cancer
    Salbutamol (Standard) is the analytical standard of Salbutamol. This product is intended for research and analytical applications. Salbutamol (Albuterol) is a short-acting beta-2 adrenergic receptor agonist with oral activity. Salbutamol promotes tumorigenesis of gastric cancer cells through the β2-AR/ERK/EMT pathway. Salbutamol is used to study bronchospasms caused by asthma and chronic obstructive pulmonary disease (COPD) .
    Salbutamol (Standard)
  • HY-14205
    NW-1772 methanesulfonate

    		Monoamine Oxidase Neurological Disease
    NW-1772 (methanesulfonate) (22b) is a potent and selective monoamine oxidase (MAO) B inhibitor. NW-1772 (methanesulfonate) is the equivalent of HY-111156 NW-1772. NW-1772 has some advantages, such as rapid blood-brain barrier penetration, short-acting and reversible inhibitory activity, slight inhibition of selected cytochrome P450s, and low in vitro toxicity. NW-1772 can be used for the research of neurodegenerative diseases .
    NW-1772 methanesulfonate
  • HY-B1510
    Acrivastine

    BW825C

    		 Histamine Receptor Inflammation/Immunology Endocrinology
    Acrivastine (BW825C) is a short acting histamine 1 receptor antagonist for the treatment of allergic rhinitis.
    Acrivastine
  • HY-B1510S
    Acrivastine D7

    BW825C d7

    		 Histamine Receptor Inflammation/Immunology Endocrinology
    Acrivastine-d7 is a deuterium labeled Acrivastine. Acrivastine is a short acting histamine 1 receptor antagonist.
    Acrivastine D7
  • HY-B1830
    Estradiol enanthate

    		Estrogen Receptor/ERR Endocrinology
    Estradiol enanthate is a shorter-acting estrogen. The combination of Estradiol enanthate and dihydroxyprogesterone acetophenide can be used as a monthly injectable contraceptive .
    Estradiol enanthate
  • HY-B0321
    Tropicamide
    2 Publications Verification

    Ro 1-7683

    		 mAChR Neurological Disease
    Tropicamide (Ro 1-7683) is a selective M4 muscarinic acetylcholine receptor antagonist. Tropicamide produces short acting mydriasis (dilation of the pupil) and cycloplegia when applied as eye drops .
    Tropicamide
  • HY-B1675
    Levalbuterol

    (R)-Albuterol; (R)-Salbutamol; Levosalbutamol
    Levalbuterol ((R)-Albuterol; (R)-Salbutamol) is a short-acting β2-adrenergic receptor agonist and the active (R)-enantiomer of Salbutamol. Levalbuterol is a more potent bronchodilator than Salbutamol and has the potential for the treatment of COPD .
    Levalbuterol
  • HY-100607A
    Landiolol hydrochloride

    ONO1101 hydrochloride

    		 Adrenergic Receptor Cardiovascular Disease Endocrinology
    Landiolol hydrochloride (ONO1101 hydrochloride) is a highly beta1 selective ultra-short acting beta-blocker (β1/β2 selectivity = 255:1, a half-life of 4 min)， acts as an adrenoceptor antagonist .
    Landiolol hydrochloride
  • HY-B0321S
    Tropicamide-d3

    Ro 1-7683-d3

    		 mAChR Neurological Disease
    Tropicamide-d3 is the deuterium labeled Tropicamide[1]. Tropicamide (Ro 1-7683) is a selective M4 muscarinic acetylcholine receptor antagonist. Tropicamide produces short acting mydriasis (dilation of the pupil) and cycloplegia when applied as eye drops[2][3].
    Tropicamide-d3
  • HY-B0321R
    Tropicamide (Standard)

    Ro 1-7683 (Standard)

    		 mAChR Neurological Disease
    Tropicamide (Standard) is the analytical standard of Tropicamide. This product is intended for research and analytical applications. Tropicamide (Ro 1-7683) is a selective M4 muscarinic acetylcholine receptor antagonist. Tropicamide produces short acting mydriasis (dilation of the pupil) and cycloplegia when applied as eye drops .
    Tropicamide (Standard)

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: